Page last updated: 2024-08-25

fangchinoline and Cancer of Pancreas

fangchinoline has been researched along with Cancer of Pancreas in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lee, HS; Lee, SO; Safe, S	1

Other Studies

1 other study(ies) available for fangchinoline and Cancer of Pancreas

Article	Year
Inactivation of the orphan nuclear receptor NR4A1 contributes to apoptosis induction by fangchinoline in pancreatic cancer cells. Toxicology and applied pharmacology, 2017, 10-01, Volume: 332 Topics: Antineoplastic Agents; Apoptosis; Benzylisoquinolines; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum Stress; Humans; Inhibitor of Apoptosis Proteins; Nuclear Receptor Subfamily 4, Group A, Member 1; Oxidative Stress; Pancreatic Neoplasms; Reactive Oxygen Species; Sp1 Transcription Factor; Stephania tetrandra; Survivin	2017

Article

Year

Inactivation of the orphan nuclear receptor NR4A1 contributes to apoptosis induction by fangchinoline in pancreatic cancer cells.

Toxicology and applied pharmacology, 2017, 10-01, Volume: 332

Topics: Antineoplastic Agents; Apoptosis; Benzylisoquinolines; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum Stress; Humans; Inhibitor of Apoptosis Proteins; Nuclear Receptor Subfamily 4, Group A, Member 1; Oxidative Stress; Pancreatic Neoplasms; Reactive Oxygen Species; Sp1 Transcription Factor; Stephania tetrandra; Survivin

2017